Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nu Skin Enterprises Sees Q2 GAAP EPS $0.20-$0.30 vs $0.24 Est; Sees Sales $355.000M-$390.000M vs $376.68M Est

Author: Benzinga Newsdesk | May 08, 2025 03:59pm
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.20-$0.30 vs $0.24 analyst estimate. sees sales of $355.000 million-$390.000 million vs $376.68 million analyst estimate.

Posted In: NUS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist